Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 620-631
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.620
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.620
Generation of DES | Drug eluted | Some commercially available products | Features |
First generation | Sirolimus, Paclitaxel | TAXUS, CYPHER | High Incidence of stent thrombosis, subacute as well as late thrombosis |
Second generation | Zotarolimus, Everolimus | ENDEAVOR,XIENCE V | Safer and more efficacious as compared to first generation stents |
Third generation | Novolimus, Biolimus A9 | SYNERGY, BIOMATRIX, NOBORI, DESyne | Newer generation biodegradable stents which have shown superior outcomes |
- Citation: Dalal A. Organ transplantation and drug eluting stents: Perioperative challenges. World J Transplant 2016; 6(4): 620-631
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/620.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.620